|
US3549747A
(en)
|
1968-02-20 |
1970-12-22 |
Flow Pharma Inc |
Contact lens wetting solution and method of using same
|
|
US3856919A
(en)
|
1970-06-08 |
1974-12-24 |
Burton Parsons Chemicals Inc |
Ophthalmic solution
|
|
US3947573A
(en)
|
1969-12-01 |
1976-03-30 |
Burton, Parsons And Company, Inc. |
Opthalmic solution
|
|
US3767788A
(en)
|
1970-06-08 |
1973-10-23 |
Burton Parsons Chemicals Inc |
Ophthalmic solution
|
|
US3767789A
(en)
|
1971-06-21 |
1973-10-23 |
Burton Parsons & Co Inc |
Method of providing a synthetic mucus in vivo
|
|
US3987163A
(en)
|
1973-07-27 |
1976-10-19 |
Burton, Parsons And Company, Inc. |
Polystyrene sulfonate containing opthalmic solutions
|
|
US3907985A
(en)
|
1973-07-27 |
1975-09-23 |
Burton Parsons And Company Inc |
Polystyrene sulfonate containing opthalmic solutions
|
|
US4029817A
(en)
|
1973-09-24 |
1977-06-14 |
Allergan Pharmaceuticals |
Soft contact lens preserving solutions
|
|
US3920810A
(en)
|
1974-04-23 |
1975-11-18 |
Burton Parsons And Company Inc |
Polyacrylamide containing ophthalmic solutions
|
|
US4120949A
(en)
|
1977-10-05 |
1978-10-17 |
Cooper Laboratories, Inc. |
Ophthalmic solution
|
|
US4131651A
(en)
|
1977-10-25 |
1978-12-26 |
Barnes-Hind Pharmaceuticals, Inc. |
Treatment of dry eye
|
|
US4409205A
(en)
|
1979-03-05 |
1983-10-11 |
Cooper Laboratories, Inc. |
Ophthalmic solution
|
|
US4558033A
(en)
|
1983-06-06 |
1985-12-10 |
Amgen |
Potentiation of the effects of insulin by peptides
|
|
US4673649A
(en)
|
1983-07-15 |
1987-06-16 |
University Patents, Inc. |
Process and defined medium for growth of human epidermal keratinocyte cells
|
|
WO1985005036A1
(en)
|
1984-04-30 |
1985-11-21 |
The Trustees Of Columbia University In The City Of |
Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
|
|
DE3674883D1
(de)
|
1985-11-25 |
1990-11-15 |
Wako Pure Chem Ind Ltd |
Farbentwicklungsmethode in klinischen untersuchungen.
|
|
US4833257A
(en)
|
1986-07-28 |
1989-05-23 |
Arizona Board Of Regents |
Compositions of matter and methods of using same
|
|
IL80298A
(en)
|
1986-10-14 |
1993-01-31 |
Res & Dev Co Ltd |
Eye drops
|
|
JPH0739508B2
(ja)
|
1986-11-11 |
1995-05-01 |
株式会社林原生物化学研究所 |
プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
|
|
US4885163A
(en)
|
1987-02-24 |
1989-12-05 |
Eli Lilly And Company |
Topical use of IGF-II for wound healing
|
|
US4808402A
(en)
|
1987-05-29 |
1989-02-28 |
Northwestern University |
Method and compositions for modulating neovascularization
|
|
JPS63303929A
(ja)
|
1987-06-04 |
1988-12-12 |
Kanji Izumi |
創傷治療剤
|
|
US5700450A
(en)
|
1988-03-30 |
1997-12-23 |
The Trustees Of Boston University |
Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof
|
|
ZA892928B
(en)
|
1988-04-25 |
1991-01-30 |
Pro Neuron Inc |
Pharmaceutical compositions containing deoxyribonucleosides for wound healing
|
|
US5137734A
(en)
|
1989-03-22 |
1992-08-11 |
Dana Farber Cancer Institute |
Angiogenic monoglycerides
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5158935A
(en)
|
1989-05-12 |
1992-10-27 |
Chiron Corporation |
Human epidermal growth factor having substitution at position 11
|
|
US5723119A
(en)
|
1989-07-28 |
1998-03-03 |
Schering Corporation |
Method for enhancing wound healing/repair with IL-4
|
|
US5145679A
(en)
|
1989-10-05 |
1992-09-08 |
Hinson Joan B |
Topical emollient for prevention and treatment of circulatory induced lesions
|
|
US5423778A
(en)
|
1989-12-14 |
1995-06-13 |
Elof Eriksson |
System and method for transplantation of cells
|
|
US5981606A
(en)
|
1991-03-01 |
1999-11-09 |
Warner-Lambert Company |
Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
|
|
CA2108146A1
(en)
|
1991-04-11 |
1992-10-12 |
Stuart W. Mccombie |
Anti-tumor and anti-psoriatic agents
|
|
AU668509B2
(en)
|
1991-04-19 |
1996-05-09 |
Affinity Biotech, Inc. |
Convertible microemulsion formulations
|
|
JPH0543453A
(ja)
|
1991-08-20 |
1993-02-23 |
Sumitomo Pharmaceut Co Ltd |
創傷治癒促進用局所用徐放性製剤
|
|
US5591709A
(en)
|
1991-08-30 |
1997-01-07 |
Life Medical Sciences, Inc. |
Compositions and methods for treating wounds
|
|
HUT67319A
(en)
|
1991-08-30 |
1995-03-28 |
Life Medical Sciences Inc |
Compositions for treating wounds
|
|
AU3062392A
(en)
|
1991-11-04 |
1993-06-07 |
Novo Nordisk A/S |
Pdgf gel formulation
|
|
US5948898A
(en)
*
|
1992-03-16 |
1999-09-07 |
Isis Pharmaceuticals, Inc. |
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
|
|
US6537973B1
(en)
|
1992-03-16 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of protein kinase C
|
|
DE4208552A1
(de)
|
1992-03-17 |
1993-09-23 |
Liedtke Pharmed Gmbh |
Topische arzneiformen mit insulin
|
|
GB9210574D0
(en)
|
1992-05-18 |
1992-07-01 |
Ca Nat Research Council |
Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
|
|
CA2125060C
(en)
|
1993-07-02 |
1999-03-30 |
Henry P. Dabrowski |
Ophthalmic solution for artificial tears
|
|
US6485721B1
(en)
|
1994-04-25 |
2002-11-26 |
Research Development Corporation Of Japan |
Biologically active substance-secreting hybrid gel
|
|
US6028118A
(en)
|
1996-08-08 |
2000-02-22 |
Les Laboratoires Aeterna Inc. |
Methods of using extracts of shark cartilage
|
|
JP3414539B2
(ja)
|
1994-05-11 |
2003-06-09 |
有限会社ドット |
経鼻吸収用組成物
|
|
RU2198900C2
(ru)
|
1994-05-24 |
2003-02-20 |
Еда Рисерч энд Дивелопмент Ко., Лтд. |
Усовершенствованный сополимер-1 и способ его получения
|
|
JPH07316066A
(ja)
|
1994-05-26 |
1995-12-05 |
Mochida Pharmaceut Co Ltd |
創傷治癒剤
|
|
US5474978A
(en)
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5631245A
(en)
|
1995-06-06 |
1997-05-20 |
Biodynamics Pharmaceuticals, Inc. |
Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
|
|
DK0877752T3
(da)
|
1996-01-23 |
2003-09-15 |
Univ Leland Stanford Junior |
Fremgangsmåder til screening af transdominante effektorpeptider og RNA molekyler
|
|
IL126873A
(en)
*
|
1996-05-30 |
2005-09-25 |
Aventis Pharma Inc |
Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
|
|
US5869037A
(en)
|
1996-06-26 |
1999-02-09 |
Cornell Research Foundation, Inc. |
Adenoviral-mediated gene transfer to adipocytes
|
|
JPH10158188A
(ja)
|
1996-11-29 |
1998-06-16 |
Senju Pharmaceut Co Ltd |
角膜治療用組成物
|
|
GB9702943D0
(en)
|
1997-02-13 |
1997-04-02 |
Univ Manchester |
Wound healing
|
|
JPH10265405A
(ja)
|
1997-03-19 |
1998-10-06 |
Masaaki Nanbara |
インスリン含有の皮膚外用製剤
|
|
US6274712B1
(en)
|
1997-12-23 |
2001-08-14 |
3-Dimensional Pharmaceuticals, Inc. |
Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
|
|
FR2773075B1
(fr)
|
1997-12-31 |
2000-05-05 |
Cird Galderma |
Utilisation d'activateurs de ppar-gamma en dermatologie
|
|
WO1999034821A1
(en)
|
1998-01-09 |
1999-07-15 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
US6489306B2
(en)
|
1998-02-23 |
2002-12-03 |
University Of South Florida |
Method of intranasal gene transfer for protection against respiratory infection
|
|
US6335201B1
(en)
|
1998-03-06 |
2002-01-01 |
The Regents Of The University Of California |
Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility
|
|
US6376467B1
(en)
|
1998-10-09 |
2002-04-23 |
The Regents Of The University Of California |
Use of inhibitors of protein kinase C epsilon to treat pain
|
|
US6096288A
(en)
|
1998-10-12 |
2000-08-01 |
Mobil Oil Corporation |
Synthesis of the cubic mesoporous molecular sieve MCM-48
|
|
WO2000030628A2
(en)
|
1998-11-20 |
2000-06-02 |
Genentech, Inc. |
Method of inhibiting angiogenesis
|
|
US7261881B1
(en)
|
1999-05-20 |
2007-08-28 |
Yale University |
Modulation of angiogenesis and wound healing
|
|
US6541447B1
(en)
|
1999-09-01 |
2003-04-01 |
B & M Healthcare Technologies, Inc. |
Wound healing composition and method for use thereof
|
|
NZ521437A
(en)
|
2000-02-25 |
2004-04-30 |
Immunex Corp |
Integrin antagonists suitable as inhibitors of angiogenesis
|
|
AU2001245945A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Pe Corporation (Ny) |
Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
|
|
US6582713B2
(en)
|
2000-04-06 |
2003-06-24 |
Univ. Of Colorado - Colorado Springs |
Compositions and methods for promoting wound healing
|
|
US20100129332A1
(en)
|
2000-07-31 |
2010-05-27 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions for healing wounds
|
|
US20060258562A1
(en)
*
|
2000-07-31 |
2006-11-16 |
Healor Ltd. |
Methods and pharmaceutical compositions for healing wounds
|
|
CA2416788A1
(en)
|
2000-07-31 |
2002-02-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds
|
|
US20030148924A1
(en)
|
2002-07-09 |
2003-08-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions of healing wounds
|
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
US6673603B2
(en)
|
2000-09-01 |
2004-01-06 |
Modex Therapeutiques, S.A. |
Cell paste comprising keratinocytes and fibroblasts
|
|
GB2369572A
(en)
|
2000-11-29 |
2002-06-05 |
Raft Trustees Ltd |
Wound treatment composition comprising insulin
|
|
US20020119914A1
(en)
|
2000-12-26 |
2002-08-29 |
Deguang Zhu |
New uses of insulin and pancreatin
|
|
JP2002198443A
(ja)
|
2000-12-26 |
2002-07-12 |
Nec Corp |
半導体装置及びその製造方法
|
|
GB0103877D0
(en)
|
2001-02-16 |
2001-04-04 |
King S College London |
Novel Drug Delivery system
|
|
DE10109280A1
(de)
*
|
2001-02-26 |
2002-09-05 |
Peter Mayser |
Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen
|
|
US6750234B2
(en)
|
2001-03-08 |
2004-06-15 |
University Of Kentucky Research Foundation |
Methods for increasing leptin levels using nicotinic acid compounds
|
|
JP2002272831A
(ja)
|
2001-03-14 |
2002-09-24 |
Fumio Kamiyama |
創傷被覆用粘着性シート
|
|
EP1385516A1
(en)
|
2001-04-30 |
2004-02-04 |
Arachnova Therapeutics Ltd. |
The treatment of scarring and related conditions using ppar-gamma activators
|
|
AU2002319847A1
(en)
|
2001-05-23 |
2002-12-03 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New nuclear receptor cofactors and related modulators
|
|
ES2184623B1
(es)
|
2001-06-29 |
2004-09-16 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) |
Piel artificial autologa secretora de leptina y metodo de obtencion.
|
|
US20030124503A1
(en)
|
2001-12-28 |
2003-07-03 |
Olivencia-Yurvati Albert H. |
Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
|
|
WO2003059396A1
(en)
|
2002-01-11 |
2003-07-24 |
Sergei Zolotukhin |
Adiponectin gene therapy
|
|
RU2249467C2
(ru)
|
2002-11-25 |
2005-04-10 |
ООО Научно-производственное предприятие "ЭРЛОН", Лтд. |
Медицинский материал и изделия на его основе
|
|
US20040175384A1
(en)
|
2003-12-12 |
2004-09-09 |
Mohapatra Shyam S. |
Protein kinase C as a target for the treatment of respiratory syncytial virus
|
|
US7960148B2
(en)
*
|
2003-07-02 |
2011-06-14 |
Verenium Corporation |
Glucanases, nucleic acids encoding them and methods for making and using them
|
|
AU2004259000A1
(en)
|
2003-07-21 |
2005-02-03 |
Bethesda Pharmaceuticals, Inc. |
Design and synthesis of optimized ligands for PPAR
|
|
WO2005013885A2
(en)
|
2003-08-07 |
2005-02-17 |
Healor Ltd. |
Pharmaceutical compositions and methods for accelerating wound healing
|
|
EP2228069A1
(en)
|
2003-09-16 |
2010-09-15 |
Garvan Institute Of Medical Research |
Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
|
|
TW200533357A
(en)
*
|
2004-01-08 |
2005-10-16 |
Millennium Pharm Inc |
2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
|
|
US20080206270A1
(en)
*
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
WO2006086681A2
(en)
*
|
2005-02-09 |
2006-08-17 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of inhibiting smooth muscle cell migration and proliferation
|
|
EP1877424A4
(en)
*
|
2005-04-11 |
2010-09-29 |
Pharmagap Inc |
INHIBITORS OF PROTEIN KINASES AND USES THEREOF
|
|
WO2007016777A1
(en)
*
|
2005-08-05 |
2007-02-15 |
Pharmagap Inc. |
Targeted protein kinase c inhibitors and uses thereof
|
|
EP2452686A3
(en)
|
2005-08-29 |
2012-09-05 |
HealOr Ltd. |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
|
US20090306045A1
(en)
|
2005-12-22 |
2009-12-10 |
Ira Mellman |
Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease
|
|
AU2007261399A1
(en)
*
|
2006-06-20 |
2007-12-27 |
Metaproteomics, Llc |
Reduced isoalpha acid based protein kinase modulation cancer treatment
|
|
CN102755649A
(zh)
|
2007-07-30 |
2012-10-31 |
希尔洛有限公司 |
药物组合物及相关方法
|
|
US20110004955A1
(en)
*
|
2008-01-30 |
2011-01-06 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
|
US8506944B2
(en)
|
2008-05-07 |
2013-08-13 |
The Regents Of The University Of California |
Replenishment and enrichment of ocular surface lubrication
|
|
CA2751156A1
(en)
|
2009-02-24 |
2010-09-02 |
Healor Ltd. |
Visfatin therapeutic agents for the treatment of acne and other conditions
|